MarketWatch
Search documents
Winning stock investors make money spotting trends early — and this one is just starting
MarketWatch· 2025-10-17 12:31
Charlie Garcia responds to readers about why younger Americans choosing real-world activities is the real deal. ...
Fifth Third says nothing more about its Tricolor loan loss, and the stock rises
MarketWatch· 2025-10-17 12:01
Fifth Third's provision for credit losses rises but were less than analyst expectations. ...
American Express sees credit card spending accelerate, fueling a profit beat and raise
MarketWatch· 2025-10-17 11:43
Core Insights - American Express exceeded earnings expectations and raised its outlook due to strong demand for its premium Platinum card [1] Financial Performance - The company reported better-than-expected earnings, indicating robust financial health and effective management strategies [1] Market Demand - There is a notable increase in demand for the higher-priced premium Platinum card, reflecting consumer preference for premium financial products [1]
Yes, there is credit market apprehension right now. But here's why stocks will still rally into year-end, says this bull.
MarketWatch· 2025-10-17 10:38
Core Viewpoint - Fund managers are expected to increase their portfolios, which could drive the S&P 500 index to reach 7,000 points according to Tom Lee [1] Group 1 - The current market environment is characterized by a rush among fund managers to enhance their portfolios, indicating a bullish sentiment [1] - Tom Lee predicts that this influx of investment will significantly impact the S&P 500, pushing it towards the 7,000 mark [1] - The anticipated growth in the S&P 500 reflects broader confidence in the market and potential economic recovery [1]
Weight-loss drug stocks are tumbling after Trump promised their costs ‘will be much lower'
MarketWatch· 2025-10-17 10:05
Core Viewpoint - President Trump expresses skepticism regarding the effectiveness of weight-loss drugs and aims to reduce their prices [1] Group 1 - The administration is questioning the efficacy of current weight-loss medications [1] - There is a focus on making weight-loss drugs more affordable for consumers [1]
I'm 42, a single parent with $372K. I won't invest in the S&P 500.
MarketWatch· 2025-10-17 09:30
Core Viewpoint - The sentiment expressed indicates a cautious approach towards investing in stocks, particularly due to personal responsibilities such as having young children [1] Group 1 - The individual expresses discomfort with allocating significant cash into the stock market [1] - The concern for financial stability is heightened by the presence of two young children, suggesting a preference for safer investment options [1]
Banks' credit ‘cockroaches' are spooking the stock market. Here's what investors need to know.
MarketWatch· 2025-10-16 23:31
Core Viewpoint - Investors are facing challenges due to an economic-data blackout and escalating trade tensions between the U.S. and China, compounded by issues arising from a regional lender [1] Group 1 - Ongoing economic-data blackout is creating uncertainty for investors [1] - Renewed trade war tensions between the U.S. and China are adding to investor concerns [1] - A regional lender's issues are further complicating the investment landscape [1]
Why record cash in money-market funds won't necessarily flood into stocks, bonds
MarketWatch· 2025-10-16 21:43
Core Viewpoint - The significant amount of cash in money-market funds is unlikely to transition into riskier assets in the stock and bond markets, even with the Federal Reserve's recent interest-rate cuts [1] Group 1 - Money-market funds are currently holding a record amount of cash, indicating a cautious approach among investors [1] - The Federal Reserve has resumed its interest-rate-cutting cycle, which typically encourages investment in riskier assets [1] - Despite the favorable conditions for investing, the research from J.P. Morgan suggests that this cash will not flow into the stock and bond markets [1]
Trump rolls out his latest deal with a drugmaker. This one stems from his campaign promise to cover all IVF costs.
MarketWatch· 2025-10-16 20:57
President Donald Trump on Thursday announced a deal with EMD Serono, a subsidiary of German drugmaker Merck KGaA, that aims to cut the out-of-pocket costs for in vitro fertilization, with the move coming more than a year after his campaign promise to eliminate all such costs for the fertility treatment. ...
Lithium Americas is deemed vital by Trump, but investors beware, J.P. Morgan says
MarketWatch· 2025-10-16 20:45
Core Insights - Lithium Americas Corp. experienced a significant stock surge following the federal government's investment in the company [1] - J.P. Morgan cautions investors against becoming overly optimistic about the lithium production sector [1] Company Summary - The recent federal stake in Lithium Americas Corp. has positively impacted its stock performance [1] - The involvement of the federal government may indicate a strategic interest in the lithium market, which is crucial for electric vehicle batteries and renewable energy technologies [1] Industry Summary - The lithium production industry is currently under scrutiny, with analysts highlighting potential overvaluation risks despite recent positive developments [1] - J.P. Morgan's warning suggests that while there is optimism in the sector, investors should remain cautious about future market dynamics and pricing [1]